Citations

Clear

4802 citation(s) found for "Yu, Jennifer".

Level I PD‐MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia
Boel, Judith A., Bie, Rob M.A. de , Schmand, Ben , Dalrymple‐Alford, John C. , Adler, Charles H. , Goldman, Jennifer G. , Tröster, Alexander I. , Geurtsen, Gert J. , Disease, MDS Study Group Mild Cognitive Impairment in Parkinson's, Halliday, Glenda M. , Antonini, Angelo , Lewis, Simon J.G. , Biundo, Roberta , Segura, Bàrbara , Williams‐Gray, Caroline H. , de Bie, Rob M A , Adler, C H , Geurtsen, Gert J , Halliday, Glenda , Goldman, Jennifer G , Antonini, Angelo , Dalrymple-Alford, John C , Lewis, Simon J G , Williams-Gray, Caroline H , Segura, Barbara , Marras, Connie , Burn, David J. , Litvan, Irene , Disease, MDS Study Group Mild Cognitive Impairment in Parkinson's

Mayo Clinic

Movement Disorders Clinical Practice | April 5, 2022 | Volume: 9 | Issue: 4 | Pages: 479-483

10.1002/mdc3.13451 | PMID 35582313 Get It

ABSTRACTBackgroundThe criteria for PD‐MCI allow the use of global cognitive tests. Their predictive value for conversion from PD‐MCI to PDD, especially compared to comprehensive neuropsychological assessment, is unknown.MethodsThe MDS PD‐MCI Study Group combined four datasets containing global cognitive tests as well as a comprehensive neuropsychological assessment to define PD‐MCI (n = 467). Risk for developing PDD was examined using a Cox model. Global cognitive tests were compared to neuropsychological test batteries (Level I&II) in determining risk for PDD.ResultsPD‐MCI based on a global cognitive test (MMSE or MoCA) increases the hazard for developing PDD (respectively HR = 2.57, P = 0.001; HR = 4.14, P = <0.001). The C‐statistics for MMSE (0.72) and MoCA (0.70) were lower than those based on neuropsychological tests (Level I = 0.82; Level II = 0.81). Sensitivity, specificity and diagnostic accuracy balance was best in Level II.ConclusionMMSE and MoCA predict conversion to PDD. However, Level II neuropsychological assessment seems the preferred assessment for PD‐MCI.
Improving the Timeliness and Efficiency of Discharge From the NICU
Kaemingk, Bethany D. , Hobbs, Candice A., Streeton, Abby C., Morgan, Katie M., Schuning, Virginia S., Melhouse, Janell K., Fang, Jennifer L. , Morgan, Katie, Schuning, Virginia S.

Mayo Clinic

Pediatrics | April 5, 2022 | Volume: 149 | Issue: 5 | Pages: No page available

10.1542/peds.2021-052759 | PMID 35490280 Get It

BACKGROUND Discharge from the NICU is a highly complex process. Multidisciplinary survey results and chart audits identified gaps in the timeliness and efficiency of discharge in our NICU. Using the define-measure-analyze-improve-control quality improvement framework, we aimed to increase the percentage of patients discharged before 11:00 am from a baseline mean of 9.4% to 50% without adversely impacting caregiver readiness to discharge. METHODS We used a fishbone diagram to identify causes of late and inefficient NICU discharge. A Pareto chart and Impact-Effort matrix were used to select targets for improvement efforts. Plan-do-study-act (PDSA) cycles established a goal unit discharge time, created a discharge checklist, prioritized rounding on discharging patients, set expectations for caregiver education completion, and increased nurse knowledge and comfort with providing caregiver education. RESULTS The mean percent of patients discharged before 11:00 am increased from 9.4% to 52.4%, exceeding our aim. Median discharge time improved from 13:30 pm to 11:15 am (P &lt; .001). Discharge was more efficient as demonstrated by significantly earlier completion of many discharge tasks. These improvements did not adversely impact reported caregiver readiness to discharge (75% vs 77%, P = .76). CONCLUSIONS Quality improvement methods can significantly improve the timeliness and efficiency of NICU discharge. Improvement in this complex process may be facilitated by a multidisciplinary team that offers diverse perspectives, unique process and methodologic knowledge, and the ability to appeal to all unit stakeholders. Lessons learned from this project may benefit other teams working to improve their ICU discharge process.
Clinic Design for Safety During the Pandemic: Safety or Teamwork, Can We Only Pick One?
Lim, Lisa , Zimring, Craig , DuBose, Jennifer R. , Fischer, Gary M. , Stroebel, Robert J. , Stroebel, Robert, Lim, Lisa

Mayo Clinic

HERD: Health Environments Research & Design Journal | April 5, 2022 | Volume: 15 | Issue: 3 | Pages: 28-41

10.1177/19375867221091310 | PMID 35380047 Get It

Objective: This article aims to illustrate the design considerations of team-based primary care clinics in response to the pandemic. Background: Due to COVID-19, physical distancing became a critical practice in our daily life, especially in healthcare settings where healthcare professionals must continue providing care to patients despite the manifold risks. Many healthcare facilities are implementing physical distancing in their clinic layouts, and healthcare professionals are adjusting their behaviors, so they can stay away from each other. Methods: A total of four team-based primary care clinics were studied to identify their lessons learned regarding safety measures and space usage during the pandemic. Results: The four team-based primary care clinics made changes to the clinic design (e.g., waiting areas, exam rooms, team workspaces), operational protocols (e.g., in-person huddles, social gatherings, staff work locations), and usage of spaces (e.g., outdoor spaces, utility rooms). Such changes enabled the implementation of safety measures during the pandemic. However, healthcare professionals also reported challenges regarding their team communication and coordination due to physical distancing and separation. Conclusions: Our findings suggest that the physical distancing may in fact contribute to less effective teamwork and patient care and negatively affect staff well-being. In this article, we ask healthcare system leaders and designers to continue supporting both safety and teamwork by paying attention to the flexibility and spatial relationships among healthcare professionals rather than fully sacrificing teamwork for safety. Also, now is the time when multidisciplinary collaborations are needed to establish and validate guidelines that can improve both factors.
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review
Dodick, David W. , Goadsby, Peter J. , Tassorelli, Cristina , Hundemer, Hans‐Peter , Bardos, Jennifer, Wenzel, Richard, Kemmer, Phebe, Conley, Robert R., Martinez, James M. , Oakes, Tina M. , Goadsby, Peter J , Dodick, David W , Ashina, Messoud

Mayo Clinic

Headache: The Journal of Head and Face Pain | April 1, 2022 | Volume: 62 | Issue: 4 | Pages: 453-472

10.1111/head.14292 | PMID 35363381 Get It

Abstract Objective To provide a review of challenges in clinical trials for the preventive treatment of cluster headache (CH) and highlight considerations for future studies. Background Current guidelines for preventive treatment of CH are largely based on off‐label therapies supported by a limited number of small randomized controlled trials. Guidelines for clinical trial design for CH treatments from the International Headache Society were last issued in 1995. Methods/Results Randomized controlled clinical trials were identified in the European and/or United States clinical trial registries with a search term of “cluster headache,” and manually reviewed. Cumulatively, there were 27 unique placebo‐controlled prevention trials for episodic and/or chronic CH, of which 12 were either ongoing, not yet recruiting, or the status was unknown. Of the remaining 15 trials, 5 were terminated early and 7 of the 10 completed trials enrolled fewer patients than planned or did not report the planned sample size. A systematic search of PubMed was also utilized to identify published manuscripts reporting results from placebo‐controlled preventive trials of CH. This search yielded 16 publications, of which 7 were registered. Through critical review of trial data and published manuscripts, challenges and complexities encountered in clinical trials for the preventive treatment of CH were identified. For example, the excruciating pain associated with CH demands a suitably limited baseline duration, rapid treatment efficacy onset, and poses a specific issue regarding duration of investigational treatment period and length of exposure to placebo. In episodic CH, spontaneous remission as part of natural history, and the unpredictability and irregularity of cluster periods across patients present additional key challenges. Conclusions Optimal CH trial design should balance sound methodology to demonstrate efficacy of a potential treatment with patient needs and the natural history of the disease, including unique outcome measures and endpoint timings for chronic versus episodic CH.
The state-of-the-art pharmacotherapeutic options for the treatment of chronic non-cancer pain
D’Souza, Ryan S. , Her, Yeng F , Schappell, Justin , Eller, Jennifer , Evans, Timothy C., Hagedorn, Jonathan M. , Langford, Brendan , Wilson, Rachel E, Eller, Jennifer S, Hagedorn, Jonathan M , D'Souza, Ryan S , Wilson, Rachel E.

Mayo Clinic

Expert Opinion on Pharmacotherapy | March 31, 2022 | Volume: 23 | Issue: 7 | Pages: 775-789

10.1080/14656566.2022.2060741 | PMID 35354341 Get It

Management of Patients on Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Peri-Endoscopic Period: A Clinical Practice Guideline Dissemination Tool
Barkun, Alan , Douketis, James D. , Laine, Loren , Telford, Jennifer J. , Abraham, Neena S. , Douketis, James, Telford, Jennifer J , Barkun, Alan N , Noseworthy, Peter A.

Mayo Clinic

American Journal of Gastroenterology | March 31, 2022 | Volume: 117 | Issue: 4 | Pages: 513-519

10.14309/ajg.0000000000001688 | PMID 35354773 Get It

A Scoping Review of Labor and Organ Trafficking Resources for U.S. Healthcare Professionals
Talbott, Jennifer , Titchen, KE, Mishra, N, Kling, JM, Talbott, Jennifer M V

Mayo Clinic

Journal of Human Trafficking | March 29, 2022 | Volume: 10 | Issue: 3 | Pages: 465-478

10.1080/23322705.2022.2054616 Get It

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
Klonoff, David C. , Wang, Jing , Rodbard, David , Kohn, Michael A. , Li, Chengdong , Liepmann, Dorian , Kerr, David , Ahn, David , Peters, Anne L. , Umpierrez, Guillermo E. , Xu, Nicole Y. , Nguyen, Kevin T. , Simonson, Gregg D. , Agus, Michael S. D. , Armaiz-Peña, Gustavo , Basu, Ananda , Battelino, Tadej , Yeshiwas, Sewagegn , Bequette, B. Wayne , Blevins, Thomas , Breton, Marc D. , Castle, Jessica R. , Close, Kelly L. , Drincic, Angela, Dungan, Kathleen , Ejskjær, Niels , Espinoza, Juan , Fleming, G. Alexander , Forlenza, Gregory P. , Freckmann, Guido , Galindo, Rodolfo J. , Gómez, Ana María , Gutow, Hanna A. , Hovorka, Roman , Ji, Linong , Joubert, Michaël , Koliwad, Suneil K. , Lal, Rayhan , Lansang, M. Cecilia , Lee, Wei-An , Leelarathna, Lalantha , Lind, Marcus , Mahoney, Katherine , Mankovsky, Boris , Masharani, Umesh , Mathioudakis, Nestoras , Mayorov, Alexander Yur'evich , Messler, Jordan , Mohan, Viswanathan , Nichols, James H. , O’Neal, David N. , Pasquel, Francisco J. , Philis‐Tsimikas, Athena , Phillip, Moshe , Rayman, Gerry , Russell, Steven J. , Spanakis, Elias K. , Waki, Kayo , Wallia, Amisha , Weinberg, Melissa E. , Wolpert, Howard , Zilbermint, Mihail , Kovatchev, Boris , Seley, Jane Jeffrie , Xu, Nicole Y , Nguyen, Kevin T , Simonson, Gregg , Agus, Michael S D , Al-Sofiani, Mohammed E , Armaiz-Pena, Gustavo , Bailey, Timothy S , Basu, Ananda , Battelino, Tadej , Bekele, Sewagegn Yeshiwas , Benhamou, Pierre-Yves , Bequette, B Wayne , Blevins, Thomas , Breton, Marc D , Castle, Jessica R , Chase, James Geoffrey , Chen, Kong , Choudhary, Pratik , Clements, Mark A , Close, Kelly L , Cook, Curtiss B , Doyle, Francis J , Drincic, Angela , Dungan, Kathleen M , Edelman, Steven V , Ejskjaer, Niels , Espinoza, Juan , Fleming, G Alexander , Forlenza, Gregory P , Freckmann, Guido , Galindo, Rodolfo J , Gomez, Ana Maria , Gutow, Hanna A , Heinemann, Lutz , Hirsch, Irl B , Hoang, Thanh D , Hovorka, Roman , Jendle, Johan H , Ji, Linong , Joshi, Shashank R , Joubert, Michael , Koliwad, Suneil K , Lal, Rayhan A , Lansang, M Cecilia , Lee, Wei-An Andy , Leelarathna, Lalantha , Leiter, Lawrence A , Lind, Marcus , Litchman, Michelle L , Mader, Julia K , Mahoney, Katherine M , Mankovsky, Boris , Masharani, Umesh , Mathioudakis, Nestoras N , Mayorov, Alexander , Messler, Jordan , Miller, Joshua D , Mohan, Viswanathan , Nichols, James H , Nørgaard, Kirsten , O'Neal, David N , Pasquel, Francisco J , Philis-Tsimikas, Athena , Pieber, Thomas , Phillip, Moshe , Polonsky, William H , Pop-Busui, Rodica , Rayman, Gerry , Rhee, Eun-Jung , Russell, Steven J , Shah, Viral N , Sherr, Jennifer L , Sode, Koji , Spanakis, Elias K , Wake, Deborah J , Waki, Kayo , Wallia, Amisha , Weinberg, Melissa E , Wolpert, Howard , Wright, Eugene E , Zilbermint, Mihail , Kovatchev, Boris , Kohn, Michael , Umpierrez, Guillermo E. , Peters, Anne L , Ahn, David T , Liepmann, Dorian , Bailey, Timothy S. , Chen, Kong Y. , Choudhary, Pratik , Cook, Curtiss B. , Danne, Thomas , Doyle, Francis J. , Heinemann, Lutz , Hirsch, Irl B. , Leiter, Lawrence A. , Mader, Julia K. , Pop‐Busui, Rodica , Shah, Viral N. , Sode, Koji , Wright, Eugene E.

Mayo Clinic

Journal of Diabetes Science and Technology | March 29, 2022 | Volume: 17 | Issue: 5 | Pages: 1226-1242

10.1177/19322968221085273 | PMID 35348391 Get It

Background: A composite metric for the quality of glycemia from continuous glucose monitor (CGM) tracings could be useful for assisting with basic clinical interpretation of CGM data. Methods: We assembled a data set of 14-day CGM tracings from 225 insulin-treated adults with diabetes. Using a balanced incomplete block design, 330 clinicians who were highly experienced with CGM analysis and interpretation ranked the CGM tracings from best to worst quality of glycemia. We used principal component analysis and multiple regressions to develop a model to predict the clinician ranking based on seven standard metrics in an Ambulatory Glucose Profile: very low–glucose and low-glucose hypoglycemia; very high–glucose and high-glucose hyperglycemia; time in range; mean glucose; and coefficient of variation. Results: The analysis showed that clinician rankings depend on two components, one related to hypoglycemia that gives more weight to very low-glucose than to low-glucose and the other related to hyperglycemia that likewise gives greater weight to very high-glucose than to high-glucose. These two components should be calculated and displayed separately, but they can also be combined into a single Glycemia Risk Index (GRI) that corresponds closely to the clinician rankings of the overall quality of glycemia (r = 0.95). The GRI can be displayed graphically on a GRI Grid with the hypoglycemia component on the horizontal axis and the hyperglycemia component on the vertical axis. Diagonal lines divide the graph into five zones (quintiles) corresponding to the best (0th to 20th percentile) to worst (81st to 100th percentile) overall quality of glycemia. The GRI Grid enables users to track sequential changes within an individual over time and compare groups of individuals. Conclusion: The GRI is a single-number summary of the quality of glycemia. Its hypoglycemia and hyperglycemia components provide actionable scores and a graphical display (the GRI Grid) that can be used by clinicians and researchers to determine the glycemic effects of prescribed and investigational treatments.
Author response: P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis
Cram, Jennifer Patritti , Coover, Robert A. , Rizvi, Tilat A. , Chaney, Katherine E. , Ravindran, Ramya , Spinner, Robert J. , Wu, Jianqiang , Cancelas, José A. , Ratner, Nancy

Mayo Clinic

No container title available | March 28, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.73511.sa2 Get It

COVID-19 FAQs in Pediatric Cardiac Surgery: 2022 Perspective and Updates
Levy, Emily R. , Dearani, Joseph A. , Blumenthal, Jennifer , Johnson, Jonathan N. , Overman, David M. , Stephens, Elizabeth H. , Dearani, Joseph A. , Levy, Emily R , Chiotos, Kathleen

Mayo Clinic

World Journal for Pediatric and Congenital Heart Surgery | March 28, 2022 | Volume: 13 | Issue: 3 | Pages: 287-292

10.1177/21501351221085966 | PMID 35341384 Get It